Dexamethasone sodium phosphate Ophthalmic Solution Rx
Generic Name and Formulations:
Dexamethasone sodium phosphate 0.1%; oph soln; contains benzalkonium chloride.
Indications for Dexamethasone sodium phosphate Ophthalmic Solution:
Steroid responsive inflammatory conditions of the eye.
Initial therapy: 1 or 2 drops in conjunctival sac every hour during the day and every two hours during the night. When favorable response observed, reduce dose to 1 drop every 4 hours; may reduce later to 1 drop 3 or 4 times daily.
Epithelial herpes simplex keratitis. Acute infectious stages of vaccinia, varicella, and many other diseases of the cornea and conjunctiva. Mycobacterial infection of the eye. Fungal diseases of ocular or auricular structures. Perforation of a drum membrane.
Monitor intraocular pressure if used for >10 days. Wait at least 15 minutes before inserting contact lenses. Pregnancy (Cat.C). Nursing mothers: not recommended.
Glaucoma with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection from pathogens including herpes simplex, perforation of the globe; rare: stinging, burning, filtering blebs following cataract surgery.
Neurology Advisor Articles
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Patients With Multiple Sclerosis Face Greater Infection Risk
- Fingolimod Compared With Glatiramer Acetate in Head-to-Head MS Study
- Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure